Yun Oh

Phase 2 study of mapatumumab, a fully human agonistic monoclonal antibody which targets and activates the TRAIL receptor-1, in patients with advanced non-small cell lung cancer

F. Anthony Greco, Philip Bonomi, Jeffrey Crawford et al. · Lung Cancer · 2008 · 164 citations

Medicine, Oncology, Pharmacology +17

Number of metastatic sites is a strong predictor of survival in patients with nonsmall cell lung cancer with or without brain metastases

Yun Oh, Sarah Taylor, B. Nebiyou Bekele et al. · Cancer · 2009 · 135 citations · Full text

Medicine, Oncology, Metastasis +15

A Phase 1 Dose Escalation, Pharmacokinetic, and Pharmacodynamic Evaluation of eIF-4E Antisense Oligonucleotide LY2275796 in Patients with Advanced Cancer

David S. Hong, Razelle Kurzrock, Yun Oh et al. · Clinical Cancer Research · 2011 · 131 citations · Full text

Medicine, Oncology, Pharmacology +17

Phase II study of pemetrexed in combination with carboplatin in the first‐line treatment of advanced nonsmall cell lung cancer

Ralph Zinner, Frank V. Fossella, Gregory W. Gladish et al. · Cancer · 2005 · 88 citations · Full text

Medicine, Oncology, Pharmacology +13

Current status of gene therapy for lung cancer and head and neck cancer.

Chulso Moon, Yun Oh, Jack A. Roth · PubMed · 2003 · 76 citations

Medicine, Cancer Biology, Oncology +17